ClariPi to Showcase its AI Medical Imaging Solutions at RSNA 2021

ClariPi, a leading AI medical imaging company, is presenting its AI-powered low-dose CT denoising solution, ClariCT.AI along with new innovative AI imaging solutions at RSNA 2021. ClariCT.AI is a vendor-agnostic software solution offering a superb clarity of CT images scanned with substantially reduced radiation dose, both FDA-cleared and CE-marked. 

Trained with world’s largest image dataset over 1 million, its deep-learned Clarity Engine clears image noise safely while enhancing underlying structures to a level of regular dose images from the noisy ultra-low-dose CTs. Hyun-Sook Park, co-CEO of ClariPi said, “We are proud to see more clinical studies being published proving the efficacy of ClariCT.AI. We hope to collaborate with more partners to open the door to the age of ultra-low-dose CT where patients get CT scans without radiation anxiety any longer.”

ClariPi presented its new innovations at the AI Theater under the topic of ‘Bringing the Power of AI into Ultra-Low-Dose CT Imaging: ClariPi Inc.’ on Sunday, November 28. Harry Park, president of Global Sales & Marketing at ClariPi USA said, “We debuted another innovative product ClariACE, a software-based iodine contrast boost solution to address the need to minimize contrast medium side-effects in contrast-enhanced CT scans.” “On top of these, we also introduced ClariPulmo, a fully automated AI-powered 3D reporting solution for COVID-19 pneumonia and emphysema, along with ClariOsteo, an AI-powered precision bone healthcare solution both with low-dose and ultra-low-dose CT images.”

“With the Nuance AI Marketplace, we are one step closer to our vision- implementation is simplified, having the ClariCT.AI on the Nuance AI Marketplace will insure easy accessibility through cloud-based distribution and deployment.” said Jong-Hyo Kim, CTO and co-CEO of ClariPi.

SourceClariPi
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy